Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochem Pharmacol ; 193: 114744, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34453903

RESUMO

PURPOSE: Cardiac transition from concentric (C-LVH) to eccentric left ventricle hypertrophy (E-LVH) is a maladaptive response of hypertension. Matrix metalloproteinases (MMPs), in particular MMP-2, may contribute to tissue remodeling by proteolyzing extra- and intracellular proteins. Troponin I and dystrophin are two potential targets of MMP-2 examined in this study and their proteolysis would impair cardiac contractile function. We hypothesized that MMP-2 contributes to the decrease in troponin I and dystrophin in the hypertensive heart and thereby controls the transition from C-LVH to E-LVH and cardiac dysfunction. METHODS: Male Wistar rats were divided into sham or two kidney-1 clip (2K-1C) hypertensive groups and treated with water (vehicle) or doxycycline (MMP inhibitor, 15 mg/kg/day) by gavage from the tenth to the sixteenth week post-surgery. Tail-cuff plethysmography, echocardiography, gelatin zymography, confocal microscopy, western blot, mass spectrometry, in silico protein analysis and immunofluorescence were performed. RESULTS: 6 out of 23 2K-1C rats (26%) had E-LVH followed by reduced ejection fraction. The remaining had C-LVH with preserved cardiac function. Doxycycline prevented the transition from C-LVH to E-LVH. MMP activity is increased in C-LVH and E-LVH hearts which was inhibited by doxycycline. This effect was associated with an increase in troponin I cleavage products and a decline in dystrophin in the left ventricle of E-LVH rats, which was prevented by doxycycline. CONCLUSION: Hypertension causes increased cardiac MMP-2 activity which proteolyzes troponin I and dystrophin, contributing to the transition from C-LVH to E-LVH and cardiac dysfunction.


Assuntos
Doxiciclina/farmacologia , Distrofina/metabolismo , Hipertensão/complicações , Hipertrofia Ventricular Esquerda/etiologia , Metaloproteinase 2 da Matriz/metabolismo , Troponina I/metabolismo , Animais , Antibacterianos/farmacologia , Distrofina/genética , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Hipertrofia Ventricular Esquerda/metabolismo , Masculino , Metaloproteinase 2 da Matriz/genética , Inibidores de Metaloproteinases de Matriz/farmacologia , Ratos , Ratos Wistar , Troponina I/genética
2.
PLoS One ; 13(12): e0209190, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30571725

RESUMO

Even though the coronary reperfusion process is the most important tool to preserve cardiac function, after myocardial infarction, reperfusion of acutely ischemic myocardium can induce injury. We aimed to evaluate the functional and molecular aspects 4 weeks after myocardial ischemia-reperfusion (IR) in rats. Male Wistar rats (N = 47) were subjected to myocardial IR by short-term (30 min) ligation and subsequent reperfusion of the left descending coronary artery. Control rats (N = 7) underwent the same surgical maneuver without coronary ligation. After 4 weeks, rats had their cardiac function examined by ventricular pressure recording under basal condition or pharmacological stress. Myocardial fibrosis and molecular mediators of IR injury (reactive oxygen species, tumor necrosis factor-alpha and matrix-metalloproteinase-2) were assessed as well. Most of the rats subjected to IR did not show macroscopic signs of infarct, while only 17% of these animals showed large myocardial infarction scars. Of note, all animals submitted to IR presented the functional and molecular parameters altered when compared with the control subjects. Cardiac function was attenuated in all animals submitted to IR, regardless the presence or size of macroscopic cardiac scars. Interstitial fibrosis, matrix-metalloproteinase-2 activity and the expression of tumor necrosis factor-alpha were higher in the myocardium of all IR rats as compared to the control subjects (p<0.05). Myocardium superoxide anion and hydrogen peroxide were increased in rats without or with mild cardiac scars. These results show that IR leads to myocardial injury in rats. Besides, even the animals with an apparent healthy myocardium (without infarct scar) presented cardiac dysfunction and molecular changes that may contribute to the development of heart failure over time.


Assuntos
Cicatriz/patologia , Cicatriz/fisiopatologia , Traumatismo por Reperfusão Miocárdica/patologia , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Animais , Cicatriz/metabolismo , Colágeno/metabolismo , Modelos Animais de Doenças , Coração/fisiopatologia , Masculino , Metaloproteinase 2 da Matriz/metabolismo , Traumatismo por Reperfusão Miocárdica/metabolismo , Miocárdio/metabolismo , Miocárdio/patologia , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Pressão Ventricular
3.
Gene ; 676: 9-15, 2018 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-29990505

RESUMO

Several studies have demonstrated dysregulated cardiac microRNAs (miRNAs) following cardiac stress and development of cardiac hypertrophy and failure. miRNAs are also differentially expressed in the inflammation that occurs in heart failure and, among these inflammatory-related miRNAs, the miR-155 has been implicated in the regulation of cardiac hypertrophy. Despite these data showing the role of miRNA-155 in cardiomyocyte hypertrophy under a hypertrophic stimulus, it is also important to understand the endogenous regulation of this miRNA without a hypertrophic stimulus to fully appreciate its function in this cell type. The first aim of the present study was to determine whether, without a hypertrophic stimulus, miR-155 overexpression induces H9c2 cardiac cells hypertrophy in vitro. The second objective was to determine whether osteoglycin (Ogn), a key regulator of heart mass in rats, mice, and humans, is post-transcriptionally regulated by miR-155 with a potential role in inducing H9c2 cells hypertrophy. Here, we show that, without a hypertrophic stimulus, miR-155 significantly repressed Ogn protein levels, but induce neither alteration in morphological phenotype nor in the expression of the molecular markers that fully characterize pathological hypertrophy of H9c2 cells. However, most importantly, Ogn silencing in H9c2 cells mimicked the effects of miR-155 overexpression in inducing cellular architecture changes that were characterized by a transition of the cell shape from fusiform to rounded. This is a new role of the post-transcriptional regulation of Ogn by miR-155 in the maintenance of the cardiac cell morphology in physiological and pathological conditions.


Assuntos
Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , MicroRNAs/genética , Mioblastos Cardíacos/citologia , Animais , Linhagem Celular , Regulação da Expressão Gênica , Inativação Gênica , Peptídeos e Proteínas de Sinalização Intercelular/genética , Mioblastos Cardíacos/metabolismo , Ratos
4.
Comput Biol Med ; 100: 36-40, 2018 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-29975852

RESUMO

The multiscale entropy (MSE1D) measure is now widely used to quantify the complexity of time series. The development of complexity measures for images is also a long-standing goal. Recently, the bi-dimensional version of MSE1D has been proposed (MSE2D) to analyze images. The interpretation of MSE2D curves and the applications to real data are still emergent. Because the coarse-graining step in the MSE2D computation changes the frequency content of the image, we hypothesized a possible dependence between MSE2D and the discrete Fourier transform (DFT). To analyze this dependence, synthetic as well as biomedical images are analyzed. Our results reveal that i) the profile of MSE2D is sensitive to both the amplitude and phase of the DFT; ii) MSE2D could find applications in the biomedical field. This work brings valuable information for MSE2D interpretation and opens possibilities to study images from an entropy point of view through spatial scales.


Assuntos
Entropia , Análise de Fourier , Processamento de Imagem Assistida por Computador , Modelos Teóricos
5.
Physiol Behav ; 144: 124-8, 2015 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-25747768

RESUMO

Depression is a predictor of poor prognosis in patients with heart failure. Selective serotonin (5-HT) reuptake inhibitors (SSRIs) may improve these outcomes. Left ventricular volume overload induced hypertrophy that is associated with aortic regurgitation (AR) leads to ventricular dysfunction and heart failure. The aim of this study was to verify the effects of the SSRI paroxetine on cardiac function, as well as on fluid intake and excretion, in subchronic AR. Male Wistar rats (260 to 280g) received sham (SH) surgery or AR induced by retrograde puncture of the aortic valve leaflets. The presence of AR was confirmed by echocardiography (ECHO) exams. Four weeks after AR surgery, subcutaneous injections of paroxetine (PAR: 10mg/kg 3 times in a week) or saline were administered. The rats were randomly divided into the following 4 groups and treated for 4 weeks: AR-PAR, ARsaline, SH-PAR and SH-saline. At the end of the treatment period, fractional shortening was preserved in AR-PAR, compared to AR-saline (46.6±2.7% vs 38.3±2.2%, respectively). Daily 0.3 M NaCl intake was reduced in PAR-treated rats. Natriuresis was increased in weeks 2-3 after PAR treatment. Our results suggest that augmentation of central 5-HT neurotransmission has a beneficial effect on cardiovascular remodeling following volume overload. The mechanisms underlying this effect are unknown.


Assuntos
Antidepressivos de Segunda Geração/uso terapêutico , Insuficiência da Valva Aórtica/complicações , Depressão/tratamento farmacológico , Depressão/etiologia , Paroxetina/uso terapêutico , Cloreto de Sódio/metabolismo , Análise de Variância , Animais , Insuficiência da Valva Aórtica/etiologia , Pressão Sanguínea/fisiologia , Modelos Animais de Doenças , Ingestão de Líquidos/fisiologia , Ecocardiografia , Frequência Cardíaca/fisiologia , Masculino , Miocárdio/patologia , Tamanho do Órgão , Potássio/metabolismo , Ratos , Ratos Wistar , Fatores de Tempo , Equilíbrio Hidroeletrolítico/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...